Fort, L.P. Royalty Pharma PLC Transaction History

Fort, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $29,198 - $35,105	-891 Reduced 11.83%	6,641 $239,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $39,522 - $44,436	1,009 Added 15.47%	7,532 $297,000
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $15,553 - $17,413	-390 Reduced 5.64%	6,523 $262,000
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $259,444 - $305,692	6,913 New	6,913 $291,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.